Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Califf: Industry Should Be Reminded Of US FDA’s Separate Development Advice, Application Assessment Roles
Sep 15 2022
•
By
Derrick Gingery
The FDA must balance its role giving scientific advice to drug developers with its mandate to provide independent and objective assessments of product applications. • Source: Shutterstock
More from RAPS
More from Pink Sheet